Cronos Group Inc. announced that Dr. Todd Abraham will retire as Chief Innovation Officer, after a distinguished 40-year career, including the last two years at Cronos Group. Arye Weigensberg, General Manager at Cronos Research Labs and Vice President of Research and Technology, has assumed the role of Head of Research and Development on an interim basis until a permanent replacement is named. The Company is conducting a search for Dr. Abraham?s successor and looks forward to appointing a successor in the near term. As interim Head of Research and Development, Arye is responsible for scientific efforts to unlock the potential of cannabis by discovering and validating the unique effects of rare cannabinoids. Before joining the Company, Arye was the CEO of Altria Israel, Altria Group Inc.?s vaporizer-focused research and development innovation hub, where he drove Altria?s vapor business forward through research, product development, technology innovation, analytics and marketing strategies.